Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Antibodies × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myelomonocytic, Juvenile 4 Leukemia, Myeloid, Acute 4 Hemoglobinuria, Paroxysmal 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Melanoma 2 Leukemia 2 Hodgkin Disease 2 Carcinoma, Hepatocellular 2 Squamous Cell Carcinoma of Head and Neck 1 Neuroblastoma 1 Lymphoma 1 Liver Neoplasms 1 Liver Diseases 1 Hemoglobinuria 1 Colorectal Neoplasms 1

Interventions

Cyclophosphamide 47 Etoposide 27 Irinotecan 25 Temozolomide 24 Melphalan 24 3-Iodobenzylguanidine 22 Topotecan 20 Filgrastim 20 Isotretinoin 19 Carboplatin 18 Granulocyte Colony-Stimulating Factor 16 sargramostim 15 fludarabine 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 humanized 3F8 anti-GD2 monoclonal antibody 14 dinutuximab 13 Peripheral Blood Stem Cell Transplantation 13 Doxorubicin 13 Cisplatin 13 Radiotherapy 12 Interleukin-2 12 Busulfan 12 naxitamab 11 Vincristine 11 fludarabine phosphate 10 aldesleukin 9 Thiotepa 9 Eflornithine 8 Vorinostat 7 Stem Cell Transplantation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02914405 2025-10-22

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡